← SynDRA
NSC-405020
SynDRA canonical compound SYN0087360 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | MMP1 |
|---|
| Mechanism of action | Matrix metalloprotease inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- Matrix metalloprotease inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- CP2C9
- CP3A4
- KSYK
- NPBW1
- NSD2
- SYK
Cross-references
Synonyms
- 3,4-dichloro-N-(pentan-2-yl)benzamide
- 3,4-dichloro-N-pentan-2-ylbenzamide
- NSC405020
- 3,4-Dichloro-N-(1-Methylbutyl)benza-Mide
- MFCD02006898
- STK029746
- orb1307234
- SCHEMBL26924143
- SCHEMBL30503030
- EX-A190
- GLXC-05068
- HMS3653L08
- BDBM50546207
- s8072
- 3,4-Dichloro-N-(2-pentyl)benzamide
- AKOS003260207
- AKOS021774952
- CCG-267051
- CS-3243
- NCGC00386282-01
- NCGC00386282-11
- AC-32904
- DA-48504
- DS-10698
- HY-15827
- SY077224
- N7211
- ST50721491
- SW219617-1
- (3,4-dichlorophenyl)-N-(methylbutyl)carboxamide
- BRD-A67975844-001-01-8
- BRD-A67975844-001-02-6
Look up NSC-405020 in the interactive SynDRA portal →